Selim Samy, Almuhayawi Mohammed S, Alruhaili Mohammed H, Saddiq Amna A, Baghdadi Afra Mohammed, Atta Roba M S, Al Jaouni Soad K
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.
Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Int J Biol Macromol. 2025 Apr;301:140376. doi: 10.1016/j.ijbiomac.2025.140376. Epub 2025 Jan 27.
This study aimed to synthesize a nanocomposite based on tertiary metal oxide FeO@CuO@ZnONPs, starch, ethylcellulose, and collagen, as well as evaluate its biological activities. The prepared nanocomposites were characterized using physicochemical analysis, which included FTIR, XRD, and DLS. Additionally, topographical analysis using FI-SEM, EDX, mapping, HR-TEM, and SAED affirmed the molecular structure and nanosized of formulated nanocomposites. Moreover, DLS performed a size of free nanocomposite (Bnanocomp) and trimetallic loaded nanocomposite (Lnanocomp) as 158 and 105 nm, respectively. The synthesized loaded nanocomposite with metal oxides (Lnanocomp) was assessed for cytotoxicity on normal and cancerous cell lines. Results revealed that the IC50 of Lnanocomp toward Wi-38 normal cell line was 196.4 μg/mL; this confirms that Lnanocomp is non-toxic and safe in use. Moreover, Lnanocomp displayed anticancer activity against Hep-G2 with IC50 53.7 μg/mL. Furthermore, Lnanocomp displayed potential antibacterial activity toward E. coli, P. aeruginosa, S. typhimurium, S. aureus, and B. subtilis with MICs 50, 50, 12.5, 50, and 25 μg/mL, respectively. Also, Lnanocomp exhibited antifungal activity where MIC was 200, 50, and 100 μg/mL toward C. albicans, A. fumigatus, and A. brasilienisis respectively. In conclusion, the prepared FeO@CuO@ZnONPs-based nanocomposite shows promising synergetic antibacterial, antifungal, and anticancer activities with state biocompatibility.
本研究旨在合成一种基于三元金属氧化物FeO@CuO@ZnO纳米颗粒、淀粉、乙基纤维素和胶原蛋白的纳米复合材料,并评估其生物活性。使用包括傅里叶变换红外光谱(FTIR)、X射线衍射(XRD)和动态光散射(DLS)在内的物理化学分析对制备的纳米复合材料进行表征。此外,使用场发射扫描电子显微镜(FI-SEM)、能谱分析(EDX)、图谱分析、高分辨率透射电子显微镜(HR-TEM)和选区电子衍射(SAED)进行的形貌分析证实了所制备纳米复合材料的分子结构和纳米尺寸。此外,动态光散射测定游离纳米复合材料(Bnanocomp)和三金属负载纳米复合材料(Lnanocomp)的尺寸分别为158和105纳米。评估了合成的负载金属氧化物纳米复合材料(Lnanocomp)对正常和癌细胞系的细胞毒性。结果显示,Lnanocomp对Wi-38正常细胞系的半数抑制浓度(IC50)为196.4微克/毫升;这证实Lnanocomp无毒且使用安全。此外,Lnanocomp对Hep-G2显示出抗癌活性,IC50为53.7微克/毫升。此外,Lnanocomp对大肠杆菌、铜绿假单胞菌、鼠伤寒沙门氏菌、金黄色葡萄球菌和枯草芽孢杆菌显示出潜在的抗菌活性,其最低抑菌浓度(MIC)分别为50、50、12.5、50和25微克/毫升。此外,Lnanocomp表现出抗真菌活性,对白色念珠菌、烟曲霉和巴西曲霉的MIC分别为200、50和100微克/毫升。总之,所制备的基于FeO@CuO@ZnO纳米颗粒的纳米复合材料显示出有前景的协同抗菌、抗真菌和抗癌活性以及良好的生物相容性。